Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
NCT01066962Phase 3Completed
- Sponsor
- ANRS
- Start
- Aug 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Aug 2010; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01066962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066962.